Ami Fadia

Needham | Healthcare

Ami Fadia is an analyst from Needham specializing in the Healthcare sector. Ranked #988 out of 4733 analysts, they have issued 73 stock ratings with a success rate of 90.95% and an average return of 24.30%.

Ami Fadia has a well-established track record, with 73 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 90.95% and an average return of 24.30%, underscoring their expertise and ability to identify winning opportunities for investors.

#988

Out of 4733

73

Total Ratings

+90.95%

Success Rate

+24.30%

Average Return

Recent Ratings Analysis

JAZZ

Jul 20, 2026

Target

$282.00

Current

$243.47

Performance

0.00%

Ami Fadia rated JAZZ as Buy on Jul 20, 2026, setting a price target of 282. Shares have remained stable near 243.47, leaving the 282 target still in play.

RVMD

Jul 20, 2026

Target

$236.00

Current

$180.39

Performance

0.00%

On Jul 20, 2026, RVMD was given a Buy rating by Ami Fadia, with a target price of 236. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.

IMRX

Jul 20, 2026

Target

$18.00

Current

$4.29

Performance

0.00%

IMRX received a Buy rating from Ami Fadia on Jul 20, 2026, aiming for 18. Price action was muted, as shares hovered around 4.29 despite the bullish outlook.

ALKS

Jul 13, 2026

Target

$62.00

Current

$51.72

Performance

-0.29%

On Jul 13, 2026, Ami Fadia published a Buy outlook on ALKS, with a target of 62. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 51.72.

MPLT

Jul 10, 2026

Target

$45.00

Current

$35.99

Performance

-8.47%

Ami Fadia on Jul 10, 2026 assigned MPLT a Buy rating, with a price target of 45. The call has struggled to gain traction, with shares losing 8.47%.

BIIB

Jun 29, 2026

Target

$256.00

Current

$199.95

Performance

-7.70%

On Jun 29, 2026, Ami Fadia reaffirmed BIIB with a Buy rating, targeting 256. Shares slid 7.70% despite the recommendation, highlighting downside risks.

PRAX

Jun 29, 2026

Target

$575.00

Current

$304.43

Performance

-13.16%

PRAX was rated Buy by Ami Fadia on Jun 29, 2026, with a price objective of 575. This case shows how bullish projections can fail, with the stock now below 304.43.

DFTX

Jun 23, 2026

Target

$50.00

Current

$42.80

Performance

18.30%

On Jun 23, 2026, Ami Fadia initiated coverage on DFTX with a Buy rating and target of 50. The stock’s climb of 18.30% since the call highlights the foresight in the rating.

NMRA

Jun 16, 2026

Target

$5.00

Current

$1.63

Performance

4.49%

Ami Fadia issued a Buy recommendation for NMRA on Jun 16, 2026, price target set at 5. The target of 5 remains in play, though confirmation will depend on future moves.

AXSM

May 05, 2026

Target

$267.00

Current

$221.64

Performance

-0.64%

On May 05, 2026, AXSM was evaluated by Ami Fadia, who gave a Buy rating and target of 267. So far, the Buy call awaits clearer momentum, with shares flat at 221.64.

NBIX

Apr 06, 2026

Target

$185.00

Current

$173.00

Performance

30.59%

Ami Fadia rated NBIX as Buy on Apr 06, 2026, setting a price target of 185. The call has proven timely, with shares rising 30.59% toward the price target of 185.

BCYC

Mar 18, 2026

Target

$15.00

Current

$4.16

Performance

-11.49%

On Mar 18, 2026, BCYC was given a Buy rating by Ami Fadia, with a target price of 15. Despite the Buy call, shares fell from 4.16 to 4.16, challenging the optimistic stance.

ATAI

Mar 09, 2026

Target

$14.00

Current

$7.19

Performance

84.83%

ATAI received a Buy rating from Ami Fadia on Mar 09, 2026, aiming for 14. Momentum has favored the Buy call, with shares climbing from 7.19 to 7.19, rewarding those who trusted the recommendation.

DAWN

Mar 06, 2026

Target

—

Current

$21.53

Performance

1.56%

On Mar 06, 2026, Ami Fadia published a Hold outlook on DAWN, with a target of null. Sideways action left the Hold view intact, with no major move since 21.53.

GHRS

Mar 06, 2026

Target

$32.00

Current

$27.53

Performance

72.82%

Ami Fadia on Mar 06, 2026 assigned GHRS a Buy rating, with a price target of 32. The Buy call aligned well with market performance, producing a gain of 72.82%.

HRMY

Feb 25, 2026

Target

$46.00

Current

$33.50

Performance

18.84%

On Feb 25, 2026, Ami Fadia reaffirmed HRMY with a Buy rating, targeting 46. The recommendation was supported by strong follow-through as the stock rose from 33.5 to 33.5.

COGT

Dec 08, 2025

Target

—

Current

$38.30

Performance

-4.96%

COGT was rated Hold by Ami Fadia on Dec 08, 2025, with a price objective of null. Flat performance suggests the Hold view was reasonable.

ACAD

Nov 06, 2025

Target

$29.00

Current

$25.09

Performance

15.89%

On Nov 06, 2025, Ami Fadia initiated coverage on ACAD with a Buy rating and target of 29. The stock’s climb of 15.89% since the call highlights the foresight in the rating.

AVDL

Oct 22, 2025

Target

—

Current

$21.64

Performance

16.85%

Ami Fadia issued a Hold recommendation for AVDL on Oct 22, 2025, price target set at null. A neutral call gave way to stronger-than-expected performance, closing in on null.

MNMD

Oct 13, 2025

Target

$28.00

Current

$20.69

Performance

68.90%

On Oct 13, 2025, MNMD was evaluated by Ami Fadia, who gave a Buy rating and target of 28. This case illustrates how a timely bullish rating can translate into tangible gains of 68.90%.

MRUS

Sep 29, 2025

Target

$96.00

Current

$90.00

Performance

-3.92%

Ami Fadia rated MRUS as Hold on Sep 29, 2025, setting a price target of 96. The Hold stance appears justified, as shares hovered around 90 with a -3.92% move.

SAGE

Jun 16, 2025

Target

—

Current

$8.68

Performance

-4.30%

On Jun 16, 2025, SAGE was given a Hold rating by Ami Fadia, with a target price of null. Market indecision, reflected in sideways trading near 8.68, supported the cautious call.

BPMC

Apr 08, 2025

Target

$133.00

Current

$129.46

Performance

63.42%

BPMC received a Buy rating from Ami Fadia on Apr 08, 2025, aiming for 133. Momentum has favored the Buy call, with shares climbing from 129.46 to 129.46, rewarding those who trusted the recommendation.

ITCI

Feb 21, 2025

Target

—

Current

$131.87

Performance

2.54%

On Feb 21, 2025, Ami Fadia published a Hold outlook on ITCI, with a target of null. Sideways action left the Hold view intact, with no major move since 131.87.

Frequency Asked Questions

Who is Ami Fadia?

Ami Fadia is an analyst from Needham specializing in the Healthcare sector.

What is Ami Fadia's success rate?

Ami Fadia currently has a success rate of +90.95%.

How many ratings has Ami Fadia issued?

Ami Fadia has issued 73 stock ratings so far.

What is the average return of Ami Fadia's calls?

Their stock ratings have generated an average return of +24.30%.

What is Ami Fadia's ranking?

Ami Fadia is ranked #988 out of 4733 analysts.

What types of ratings does Ami Fadia give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Ami Fadia?

You can follow Ami Fadia by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Ami Fadia?

Their latest rating was a Buy on JAZZ issued on 2026-07-20.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep